Skip to main content
Premium Trial:

Request an Annual Quote

Seahorse Bioscience Acquires BioProcessors; Raises Private Cash

NEW YORK (GenomeWeb News) – Seahorse Biosciences has acquired BioProcessors, a manufacturer of systems for developing and optimizing production of biological products from mammalian cell culture, for an undisclosed sum.

Though the value of the acquisition was not disclosed, Seahorse said that concurrent with the deal it had raised $6 million in private funding from venture capital investors. Among those investors are Commonwealth Capital, Oxford Bioscience, Flagship Ventures, Life Sciences Partners, FLIR Systems, Healthcare Ventures, New Science Ventures, and HLM Venture Partners.

Billerica, Mass.-based Seahorse sells its XF Series instruments, which measure energy consumption and mitochondrial function in cells in a 24- or 96-well microplate.

Woburn, Mass.-based BioProcessors makes the SimCell System, a fully integrated cell culture automation system used for selecting clones, optimizing media, and determining the best process conditions for protein manufacturing. Among BioProcessors' customers are Amgen, Life Technologies, Pfizer, and Novo Nordisk.

"Our sales of XF series instruments tripled in 2008, and we introduced three new products to this market at the end of the year," Seahorse CEO Jay Teich said in a statement. "With the addition of the people and technologies of BioProcessors, we will expand and grow the SimCell product line and markets during the coming year."

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.